Virginia · 86301

Immunologic Analysis For Detection Of Tumor Antigen, Quantitative; Ca 19-9 in Virginia

Virginia Medicare Avg
$20.33
0% below national avg
National Medicare Avg
$20.37
All states combined
Billed Charge (VA)
$119.14
What providers submit
Est. Commercial (VA)
$44.72
National avg: $45.62
Est. Cash / Self-Pay (VA)
$48.01
Typical self-pay discount

Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.

2.1K
Services in VA
75
Providers
N/A
Min Payment
N/A
Max Payment

Top Providers in Virginia

Provider Medicare Services
Zhang, Yue MD $20.39 331
Alberico, Thomas MD $20.39 184
Nielsen, Gradon M.D. $20.39 156
Inova Health Care Services $20.39 105
Laboratory Corporation Of America... $20.39 91
Sentara Reference Lab Solutions,... $20.39 77
Chang, David M.D., PHD $20.01 50
Deeb, Ayham M.D. $20.00 49

Virginia Pricing in Context

In Virginia, CPT code 86301 (Immunologic Analysis For Detection Of Tumor Antigen, Quantitative; Ca 19-9) carries an average Medicare payment of $20.33 — 0% below the national benchmark of $20.37. 75 providers across the state submitted claims for this procedure in 2023, performing 2.1K total services. Individual payments in VA ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.

The average billed charge in Virginia is $119.14, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because Virginia sits below the national Medicare average, commercial rates in the state may also run lower than the US median.

Using RAND 2024 commercial-to-Medicare ratios for Immunology procedures, the estimated commercial insurance price in Virginia lands near $44.72, with self-pay cash prices typically around $48.01. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.

Frequently Asked Questions

How much does Immunologic Analysis For Detection Of Tumor Antigen, Quantitative; Ca 19-9 cost in Virginia?

The average Medicare payment for Immunologic Analysis For Detection Of Tumor Antigen, Quantitative; Ca 19-9 in Virginia is $20.33, which is 0% below the national average of $20.37. Providers in VA typically bill $119.14 for this procedure.

What does Immunologic Analysis For Detection Of Tumor Antigen, Quantitative; Ca 19-9 cost with insurance in Virginia?

With commercial insurance in Virginia, Immunologic Analysis For Detection Of Tumor Antigen, Quantitative; Ca 19-9 costs an estimated $44.72. Without insurance, the estimated cash price is $48.01. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.

How many providers perform Immunologic Analysis For Detection Of Tumor Antigen, Quantitative; Ca 19-9 in Virginia?

75 providers in Virginia billed Medicare for Immunologic Analysis For Detection Of Tumor Antigen, Quantitative; Ca 19-9 in 2023, performing 2.1K total services. Medicare payments ranged from N/A to N/A depending on the provider.

Is Immunologic Analysis For Detection Of Tumor Antigen, Quantitative; Ca 19-9 cheaper in Virginia than the national average?

Yes — Immunologic Analysis For Detection Of Tumor Antigen, Quantitative; Ca 19-9 costs 0% below the national average in Virginia. The state average Medicare payment is $20.33 compared to $20.37 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.

Related

Data sourced from the CMS Medicare Physician and Other Practitioners dataset. See our methodology for details. Retrieved and formatted by PlainProcedure Editorial